<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36480040</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0614</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Applied microbiology and biotechnology</Title><ISOAbbreviation>Appl Microbiol Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Biological aspects of nitrogen heterocycles for amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>43</StartPage><EndPage>56</EndPage><MedlinePgn>43-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00253-022-12317-y</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a rare, cumulative neurological deteriorating disease that disturbs the neurons (nerve cells) that control voluntary muscle movement (those muscles we choose to move). Currently, the Food and Drug Administration (FDA) approved drugs such as Radicava, Rilutek, Tiglutik, Exservan, and Nuedexta to treat ALS. Given the wide range of pharmaceutical applications of heterocyclic compounds, especially those containing the nitrogen ring systems such as pyridine, pyrimidine, and indole. These molecular frameworks have piqued the interest of medicinal chemists for further investigation in a variety of diseases. We have found several review works done on this research topic. Until now, no reviews published on the nitrogen heterocycles for treating ALS. This review examines the major causes of ALS, a brief history of medications that have been used to treat it so far, and the most recent breakthroughs in nitrogen ring systems for treating ALS. The novelty of this study provides insights on several effective synthetic techniques for nitrogen-based heterocyclic medications that operate as potent anti-inflammatory treatments and guard against ALS. KEY POINTS: &#x2022; Pharmacological activity of heterocyclic compounds. &#x2022; Neurodegenerative diseases and their drawbacks are discussed in detail. &#x2022; Recent survey of nitrogen heterocycles in treating ALS disease are highlighted.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Manjupriya</LastName><ForeName>Ravichandran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Chemistry of Heterocycles and Natural Product Research Laboratory, Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pouthika</LastName><ForeName>Kamalanathan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Chemistry of Heterocycles and Natural Product Research Laboratory, Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madhumitha</LastName><ForeName>Gunabalan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Chemistry of Heterocycles and Natural Product Research Laboratory, Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014, India. dr.g.madhumitha@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roopan</LastName><ForeName>Selvaraj Mohana</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-5610-7443</Identifier><AffiliationInfo><Affiliation>Chemistry of Heterocycles and Natural Product Research Laboratory, Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014, India. mohanaroopan.s@vit.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Microbiol Biotechnol</MedlineTA><NlmUniqueID>8406612</NlmUniqueID><ISSNLinking>0175-7598</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>N762921K75</RegistryNumber><NameOfSubstance UI="D009584">Nitrogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>7LJ087RS6F</RegistryNumber><NameOfSubstance UI="D019782">Riluzole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009584" MajorTopicYN="N">Nitrogen</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019782" MajorTopicYN="N">Riluzole</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Drugs</Keyword><Keyword MajorTopicYN="N">Heterocyclic</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">Neurological disorders</Keyword><Keyword MajorTopicYN="N">Nitrogen ring systems</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>8</Day><Hour>14</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36480040</ArticleId><ArticleId IdType="doi">10.1007/s00253-022-12317-y</ArticleId><ArticleId IdType="pii">10.1007/s00253-022-12317-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aaron C, Beaudry G, Parker JA, Therrien M (2016) Maple syrup decreases TDP-43 proteotoxicity in a Caenorhabditis elegans model of amyotrophic lateral sclerosis (ALS). J Agric Food Chem 64(17):3338&#x2013;3344. https://doi.org/10.1021/acs.jafc.5b05432</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.5b05432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad R, Postnov A, Bormans G, Versijpt J, Vandenbulcke M, Van Laere K (2016) Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer&#x2019;s disease. Eur J Nucl Med Mol Imaging 43:2219&#x2013;2227. https://doi.org/10.1007/s00259-016-3457-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-016-3457-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Pearce N (2014) Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 13(11):1108&#x2013;1113. https://doi.org/10.1016/S1474-4422(14)70219-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander GE (2022) Biology of Parkinson&#x2019;s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 6:259&#x2013;280. https://doi.org/10.31887/DCNS.2004.6.3/galexander</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2004.6.3/galexander</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquilano K, Baldelli S, Rotilio G, Ciriolo MR (2008) Role of nitric oxide synthases in Parkinson&#x2019;s disease: a review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochem Res 33:2416&#x2013;2426. https://doi.org/10.1007/s11064-008-9697-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-008-9697-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Atmaram Upare A, Gadekar PK, Sivaramakrishnan H, Naik N, Khedkar VM, Sarkar D, Choudhari A, Mohana Roopan S (2019) Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents. Bioorg Chem 86:507&#x2013;512. https://doi.org/10.1016/j.bioorg.2019.01.054</Citation></Reference><Reference><Citation>Atmaram UA, Roopan SM (2022) Biological activity of oxadiazole and thiadiazole derivatives. Appl Microbiol Biotechnol 106:3489&#x2013;3505. https://doi.org/10.1007/s00253-022-11969-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-022-11969-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt SE, O&#x2019;Neal VM, Diamond JH, Borchelt DR (2016) Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol 131(1):103&#x2013;114. https://doi.org/10.1007/s00401-015-1514-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1514-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillet A, Chanteperdrix V, Trocm&#xe9; C, Casez P, Garrel C, Besson G (2010) The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson&#x2019;s disease. Neurochem Res 35(10):1530&#x2013;1537. https://doi.org/10.1007/s11064-010-0212-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-010-0212-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee V, Shani T, Katzman B, Vyazmensky M, Papo N, Israelson A, Engel S (2016) Superoxide dismutase 1 (SOD1)-derived peptide inhibits amyloid aggregation of familial amyotrophic lateral sclerosis SOD1 mutants. ACS Chem Neurosci 7(11):1595&#x2013;1606. https://doi.org/10.1021/acschemneuro.6b00227</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00227</ArticleId></ArticleIdList></Reference><Reference><Citation>Benmohamed R, Arvanites AC, Kim J, Ferrante RJ, Silverman RB, Morimoto RI, Kirsch DR (2011) Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2:87&#x2013;96. https://doi.org/10.3109/17482968.2010.522586</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.522586</ArticleId></ArticleIdList></Reference><Reference><Citation>Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57&#x2013;69. https://doi.org/10.1038/nrn2038</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T, Zerbo RA, Balbi M, Torazza C, Frumento G, Fedele E, Milanese M (2021) Nearly 30 years of animal models to study amyotrophic lateral sclerosis: a historical overview and future perspectives. Int J Mol Sci 22(22):12236. https://doi.org/10.3390/ijms222212236</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212236</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostrom J, Brown DG, Young RJ, Keseru GM (2018) Expanding the medicinal chemistry synthetic toolbox. Nat Rev Drug Discov 17:709&#x2013;727. https://doi.org/10.1038/nrd.2018.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2018.116</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. New Eng J Med 377(2):162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral GA, Griffin-Thomas L (2009) Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med 11:No. e3. https://doi.org/10.1017/S1462399409000957</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1462399409000957</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral GA, Raborn ES, Griffin L, Dennis J, Marciano Cabral F (2008) CB2 receptors in the brain: role in central immune function. Br J Pharmacol 153:240&#x2013;251. https://doi.org/10.1038/sj.bjp.0707584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0707584</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Benmohamed R, Kim J, Smith K, Amante D, Morimoto RI, Kirsch DR, Ferrante R, Silverman RB (2012) ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis. J Med Chem 55:515&#x2013;527. https://doi.org/10.1021/jm2014277</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm2014277</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WW, Zhang XIA, Huang WJ (2016) Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep 13:3391&#x2013;3396. https://doi.org/10.3892/mmr.2016.4948</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.4948</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Oliveira T, Montezinho L, Mendes C, Firuzi O, Saso L, Oliveira PJ, Silva FS (2020) Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention. Oxid Med Cell Longev. https://doi.org/10.1155/2020/5021694</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5021694</ArticleId></ArticleIdList></Reference><Reference><Citation>Deckel AW, Tang V, Nuttal D, Gary K, Elder R (2002) Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington&#x2019;s disease transgenic mice. Brain Res 939:76&#x2013;86. https://doi.org/10.1016/S0006-8993(02)02550-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(02)02550-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Marzo V, Stella N, Zimmer A (2015) Endocannabinoid signalling and the deteriorating brain. Nat Rev Neurosci 16:30&#x2013;42. https://doi.org/10.1038/nrn3876</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3876</ArticleId></ArticleIdList></Reference><Reference><Citation>Drewry DH, Annor-Gyamfi JK, Wells CI, Pickett JE, Dederer V, Preuss F, Axtman AD (2021) Identification of pyrimidine-based lead compounds for understudied kinases implicated in driving neurodegeneration. J Med Chem. https://doi.org/10.1021/acs.jmedchem.1c00440</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.1c00440</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle MS, Lippincott-Schwartz J, Ward ME (2021) RNA transport and local translation in neurodevelopmental and neurodegenerative disease. Nat Neurosci 24:622&#x2013;632. https://doi.org/10.1038/s41593-020-00785-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00785-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Feronato SG, Silva MLM, Izbicki R, Farias TD, Shigunov P, Dallagiovanna B, Dos Santos HG (2022) Selecting genetic variants and interactions associated with amyotrophic lateral sclerosis: a group LASSO approach. J Pers Med 12(8):1330. https://doi.org/10.3390/jpm12081330</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12081330</ArticleId></ArticleIdList></Reference><Reference><Citation>Getter T, Zaks I, Barhum Y, Ben-Zur T, B&#xf6;selt S, Gregoire S, Gruzman A (2015) A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS). Chem Med Chem 10(5):850&#x2013;861. https://doi.org/10.1002/cmdc.201500045</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201500045</ArticleId></ArticleIdList></Reference><Reference><Citation>Gois AM, Mendon&#xe7;a DM, Freire MAM, Santos JR (2020) In vitro and in vivo models of amyotrophic lateral sclerosis: an updated overview. Brain Res Bull 159:32&#x2013;43. https://doi.org/10.1016/j.brainresbull.2020.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2020.03.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Reyes RE, Nava-Mesa MO, Vargas-S&#xe1;nchez K, Ariza-Salamanca D, Mora-Mu&#xf1;oz L (2017) Involvement of astrocytes in Alzheimer&#x2019;s disease from a neuroinflammatory and oxidative stress perspective. Front Mol Neurosci 10:427. https://doi.org/10.3389/fnmol.2017.00427</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00427</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, Hardiman O, Al-Chalabi A, Chio A, Savelieff MG, Kiernan MC, Feldman EL (2022) Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol 21(5):465&#x2013;479. https://doi.org/10.1016/S1474-4422(21)00414-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00414-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider A, Kretz J, Gobbi L, Ahmed H, Atz K, B&#xfc;rkler M, Ametamey SM (2019) Structure&#x2013;activity relationship studies of pyridine-based ligands and identification of a fluorinated derivative for positron emission tomography imaging of cannabinoid type 2 receptors. J Med Chem 62(24):11165&#x2013;11181. https://doi.org/10.1021/acs.jmedchem.9b01280</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.9b01280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739&#x2013;749</Citation></Reference><Reference><Citation>Jiang J, Van TM, Ganesh T, Dingledine R (2018) Discovery of 2-piperidinyl phenyl benzamides and trisubstituted pyrimidines as positive allosteric modulators of the prostaglandin receptor EP2. ACS Chem Neurosci 9(4):699&#x2013;707. https://doi.org/10.1021/acschemneuro.7b00486</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.7b00486</ArticleId></ArticleIdList></Reference><Reference><Citation>Karpuzoglu E, Ahmed SA (2006) Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide 15:177&#x2013;186. https://doi.org/10.1016/j.niox.2006.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2006.03.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerman A, Liu HN, Croul S, Bilbao J, Rogaeva E, Zinman L, Chakrabartty A (2010) Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol 119(3):335&#x2013;344. https://doi.org/10.1007/s00401-010-0646-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0646-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerwin JF Jr, Lancaster JR Jr, Feldman PL (1995) Nitric oxide: a new paradigm for second messengers. J Med Chem 38:4343&#x2013;4362. https://doi.org/10.1021/jm00022a001</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm00022a001</ArticleId></ArticleIdList></Reference><Reference><Citation>Law A, Gauthier S, Quirion R (2001) Say NO to Alzheimer&#x2019;s disease: the putative links between nitric oxide and dementia of the Alzheimer&#x2019;s type. Brain Res Rev 35:73&#x2013;96. https://doi.org/10.1016/S0165-0173(00)00051-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0173(00)00051-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond CS, Kaneb HM, Dion PA, Rouleau GA (2014) Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp Neurol 262:91&#x2013;101. https://doi.org/10.1016/j.expneurol.2014.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.04.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Kim HJ (2015) Prion-like mechanism in amyotrophic lateral sclerosis: are protein aggregates the key. Exp Neurobiol 24(1):1. https://doi.org/10.5607/en.2015.24.1.1</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.1.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo E, Burnett B, Bauermeister S, Zhou SM (2022) Identifying dynamic patterns of polypharmacy for patients with dementia from primary care electronic health records: a machine learning driven longitudinal study. https://doi.org/10.14336/AD.2022.0829</Citation></Reference><Reference><Citation>Lyon MS, Wosiski-Kuhn M, Gillespie R, Caress J, Milligan C (2019) Inflammation, immunity, and amyotrophic lateral sclerosis: I. Etiology and Pathology. Muscle Nerve 59(1):10&#x2013;22. https://doi.org/10.1002/mus.26289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26289</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnitude GF, Intranuovo F, Delre P, Abatematteo FS, Abate C, Niso M, Contino M (2020) Cannabinoid receptor subtype 2 (CB2R) in a multitarget approach: perspective of an innovative strategy in cancer and neurodegeneration. J Med Chem 63(23):14448&#x2013;14469. https://doi.org/10.3390/ijms22126359</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126359</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjupriya R, Roopan SM (2021) Carbon dots-based catalyst for various organic transformations. J Mater Sci 56(31):17369&#x2013;17410. https://doi.org/10.1007/s10853-021-06354-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10853-021-06354-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95:437&#x2013;445. https://doi.org/10.1111/j.1471-4159.2005.03380.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03380.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Rubio D, Rodr&#xed;guez-Prieto &#xc1;, Sancho P, Navarro-Gonz&#xe1;lez C, Gorr&#xed;a-Redondo N, Miquel-Leal J, Espin&#xf3;s C (2022) Protein misfolding and clearance in the pathogenesis of a new infantile onset ataxia caused by mutations in PRDX3. Hum Mol Genet 31(22):3897&#x2013;3913</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac146</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew B, Ruiz P, Pathak V, Suto MJ (2020) Development of novel small molecules for the treatment of ALS. Bioorganic Med Chem Lett 30(4):126950. https://doi.org/10.1016/j.bmcl.2020.126950</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2020.126950</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD (2011) The role of immune and inflammatory mechanisms in ALS. Curr Mol Med 11(3):246&#x2013;254. https://doi.org/10.2174/156652411795243450</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta SH, Tanner CM (2016) Role of neuroinflammation in Parkinson disease: the enigma continues. Mayo Clin Proc 91(10):1328&#x2013;1330. https://doi.org/10.1016/j.mayocp.2016.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2016.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldovan RP, Teodoro R, Gao Y, Deuther-Conrad W, Kranz M, Wang Y, Kuwabara H, Nakano M, Valentine H, Fischer S, Pomper MG, Wong DF, Dannals RF, Brust P, Horti AG (2016) Development of a high-affinity PET radioligand for imaging cannabinoid subtype 2 receptor. J Med Chem 59:7840&#x2013;7855. https://doi.org/10.1021/acs.jmedchem.6b00554</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.6b00554</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G, Spampinato AG, Cavallaro S (2017) Neuroinflammation and ALS: transcriptomic insights into molecular disease mechanisms and therapeutic targets. Mediat Inflamm. https://doi.org/10.1155/2017/7070469</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7070469</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrice JR, Gregory-Evans CY, Shaw CA (2018) Animal models of amyotrophic lateral sclerosis: a comparison of model validity. Neural Regen Res 13(12):2050. https://doi.org/10.4103/1673-5374.241445</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.241445</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee P, Li H, Sevrioukova I, Chreifi G, Mart&#xe1;sek P, Roman LJ, Silverman RB (2015) Novel 2, 4-disubstituted pyrimidines as potent, selective, and cell-permeable inhibitors of neuronal nitric oxide synthase. J Med Chem 58(3):1067&#x2013;1088. https://doi.org/10.1021/jm501719e</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm501719e</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C, O&#x2019;Brien J, Bertolotti A (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. PNAS 108(9):3548&#x2013;3553. https://doi.org/10.1073/pnas.1017275108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidoo J, De Jesus-Cortes H, Huntington P, Estill S, Morlock LK, Starwalt R, Ready JM (2014) Discovery of a neuroprotective chemical, (S)-N-(3-(3, 6-dibromo-9 H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(&#x2212;)-P7C3-S243], with improved druglike properties. J Med Chem 57(9):3746&#x2013;3754. https://doi.org/10.1021/jm401919s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm401919s</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro G, Morales P, Rodr&#xed;guez-Cueto C, Fernandez-&#x154;uiz J, Jagerovic N, Franco R (2016) Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders. Front Neurosci 10:406. https://doi.org/10.3389/fnins.2016.00406</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00406</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson A, Trotti D (2022) Altered bioenergetics and metabolic homeostasis in amyotrophic lateral sclerosis. Neurotherapeutics 19:1102&#x2013;1118. https://doi.org/10.1007/s13311-022-01262-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01262-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PH, Ramamoorthy A, Sahoo BR, Zheng J, Faller P, Straub JE, Derreumaux P (2021) Amyloid oligomers: a joint experimental/computational perspective on Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, type II diabetes, and amyotrophic lateral sclerosis. Chem Rev 121(4):2545&#x2013;2647. https://doi.org/10.1021/acs.chemrev.0c01122</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.0c01122</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordstrom U, Lang L, Ekhtiari Bidhendi E, Zetterstr&#xf6;m P, Oliveberg M, Danielsson J, Marklund SL (2022) Mutant SOD1 aggregates formed in vitro and in cultured cells are polymorphic and differ from those arising in the CNS. J Neurochem. https://doi.org/10.1111/jnc.15718</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15718</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak RJ, Cuny GD, Choi S, Lansbury PT, Ray SS (2010) Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods. J Med Chem 53:2709&#x2013;2718. https://doi.org/10.1021/jm901062p</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm901062p</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524&#x2013;526. https://doi.org/10.1038/327524a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/327524a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Panio A, Cava C, D&#x2019;Antona S, Bertoli G, Porro D (2022) Diagnostic circulating miRNAs in sporadic amyotrophic lateral sclerosis.&#xa0;Front. Med 1207.&#xa0; https://doi.org/10.3389/fmed.2022.861960</Citation></Reference><Reference><Citation>Pansarasa O, Garofalo M, Scarian E, Dragoni F, Garau J, Di Gerlando R, Gagliardi S (2022) Biomarkers in human peripheral blood mononuclear cells: the state of the art in amyotrophic lateral sclerosis. Int J Mol Sci 23(5):2580</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052580</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, Trojanowski JQ, Lee VMY (2020) Protein transmission in neurodegenerative disease. Nat Rev Neurol 16:199&#x2013;212. https://doi.org/10.1038/s41582-020-0333-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0333-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray SS, Nowak RJ, Brown RH, Lansbury PT Jr (2005) Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proc Natl Acad Sci USA 102:3639&#x2013;3644. https://doi.org/10.1073/pnas.0408277102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0408277102</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifai OM, Longden J, O&#x2019;Shaughnessy J, Sewell M DE, Pate J, McDade K, Daniels MJ, Abrahams S, Chandran S, McColl BW, Sibley CR, Gregory JM (2022) Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72&#x2010;ALS . J Pathol 258:366&#x2013;381. https://doi.org/10.1002/path.6008</Citation></Reference><Reference><Citation>Russo EB (2017) Cannabidiol claims and misconceptions. Trends Pharmacol Sci 38(3):198&#x2013;201. https://doi.org/10.1016/j.tips.2016.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2016.12.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Salado IG, Redondo M, Bello ML, Perez C, Liachko NF, Kraemer BC, Miguel L, Lecourtois M, Gil C, Martinez A, Perez DI (2014) Protein kinase ck-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. J Med Chem 57:2755&#x2013;2772. https://doi.org/10.1021/jm500065f</Citation></Reference><Reference><Citation>Santos JR, Gois AM, Mendon&#xe7;a DM, Freire MA (2014) Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer&#x2019;s disease. Front Ag Neurosci 6:206. https://doi.org/10.3389/fnagi.2014.00206</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00206</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker JL, Seely KA, Reed RL, Crow JP, Prather PL (2007) The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J Neurochem 101:87&#x2013;98. https://doi.org/10.1111/j.1471-4159.2006.04346.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.04346.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Sahu K, Singh C, Singh A (2022) Lipopolysaccharide induced altered signaling pathways in various neurological disorders. Naunyn Schmiedebergs Arch Pharmacol 395:285&#x2013;294. https://doi.org/10.1007/s00210-021-02198-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-021-02198-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Sironi F (2022) Loss of C9orf72 Function impairs the peripheral neuromuscular system and anticipates symptoms in ALS mice&#xa0;(Doctoral dissertation, The Open University).</Citation></Reference><Reference><Citation>Song OM, Longden J, O&#x2019;Shaughnessy J, Sewell MD, Pate J, McDade K, Gregory JM (2022a) Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72-ALS. J Pathol 258(4):366&#x2013;381. https://doi.org/10.1002/path.6008</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6008</ArticleId></ArticleIdList></Reference><Reference><Citation>Song B, Marco-Sola S, Moreto M, Johnson L, Buckler ES, Stitzer MC (2022b) AnchorWave: sensitive alignment of genomes with high sequence diversity, extensive structural polymorphism, and whole-genome duplication. PNAS 119(1):e2113075119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113075119</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli F, Mu L, Ametamey SM (2017) Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor. J Labelled Compd Radiopharm 61:299&#x2013;308. https://doi.org/10.1002/jlcr.3579</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlcr.3579</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern E, Lambert DM (2007) Medicinal chemistry endeavors around the phytocannabinoids. Chem Biodivers 4(8):1707&#x2013;1728. https://doi.org/10.1002/cbdv.200790149</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbdv.200790149</ArticleId></ArticleIdList></Reference><Reference><Citation>Su FC, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, Feldman EL (2016) The role of environmental toxins on ALS: a case-control study of occupational risk factors. JAMA Neurol 73(7):803. https://doi.org/10.1001/jamaneurol.2016.0594</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.0594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney JB, Rattray M, Pugh V, Powell LA (2018) Riluzole&#x2013;triazole hybrids as novel chemical probes for neuroprotection in amyotrophic lateral sclerosis. ACS Medicinal Chem Lett 9(6):552&#x2013;556. https://doi.org/10.1021/acsmedchemlett.8b00103</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsmedchemlett.8b00103</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, Suzumura A (2011) Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer&#x2019;s disease. PLoS ONE 6(6):e21108. https://doi.org/10.1371/journal.pone.0021108</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HY, Yong YK, Xue YC, Liu H, Furihata T, Shankar EM, Ng CS (2022) cGAS and DDX41-STING mediated intrinsic immunity spreads intercellularly to promote neuroinflammation in SOD1 ALS model. Iscience 25(6):104404. https://doi.org/10.1016/j.isci.2022.104404</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104404</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AP, Robinson RP, Fobian YM, Blakemore DC, Jones LH, Fadeyi O (2016) Modern advances in heterocyclic chemistry in drug discovery. Org Biomol Chem 14:6611&#x2013;6637. https://doi.org/10.1039/C6OB00936K</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6OB00936K</ArticleId></ArticleIdList></Reference><Reference><Citation>Trippier PC, Zhao KT, Fox SG, Schiefer IT, Benmohamed R, Moran J, Silverman RB (2014) Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis. ACS Cheml Neurosci 5(9):823&#x2013;829. https://doi.org/10.1021/cn500147v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cn500147v</ArticleId></ArticleIdList></Reference><Reference><Citation>Turcotte C, Blanchet MR, Laviolette M, Flamand N (2016) The CB2 receptor and its role as a regulator of inflammation. Cell Mol Life Sci 73:4449&#x2013;4470. https://doi.org/10.1007/s00018-016-2300-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2300-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S, Khurana S, Vats A, Sahu B, Ganguly NK, Chakraborti P, Taneja V (2022) Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol Neurobiol 59:1502&#x2013;1527. https://doi.org/10.1007/s12035-021-02658-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02658-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent SR (1994) Nitric oxide: a radical neurotransmitter in the central nervous system. Prog Neurobiol 42:129&#x2013;160. https://doi.org/10.1016/0301-0082(94)90023-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0301-0082(94)90023-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitaku E, Smith DT, Njardarson JT (2014) Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among US FDA approved pharmaceuticals. J Med Chem 57:10257&#x2013;10274. https://doi.org/10.1021/jm501100b</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm501100b</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HY, Qin Y, Li H, Roman LJ, Mart&#xe1;sek P, Poulos TL, Silverman RB (2016) Potent and selective human neuronal nitric oxide synthase inhibition by optimization of the 2-aminopyridine-based scaffold with a pyridine linker. J Med Chem 59(10):4913&#x2013;4925. https://doi.org/10.1021/acs.jmedchem.6b00273</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.6b00273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang Q, Han X, Ma Y, Zhang Z, Zhao L, Ma S (2021) Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention. Food Func 12(9):3820&#x2013;3830. https://doi.org/10.1039/D0FO03153D</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0FO03153D</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, De SK, Kulinich A, Salem AF, Koeppen J, Wang R, Pellecchia M (2017) Potent and selective EphA4 agonists for the treatment of ALS. Cell Chem Bio 24(3):293&#x2013;305. https://doi.org/10.1016/j.chembiol.2017.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2017.01.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia G, Benmohamed R, Kim J, Arvanites AC, Morimoto RI, Ferrante RJ, Silverman RB (2011) Pyrimidine-2, 4, 6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis. J Med Chem 54(7):2409&#x2013;2421. https://doi.org/10.1021/jm101549k</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm101549k</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251&#x2013;253. https://doi.org/10.1038/nn2047</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuval G, Nicole P, Krushna S, Penelope N, Ricardo LM, Lyn RS (2022). Functional and structural consequences of TBK1 missense variants in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurobiol Dis 105859.&#xa0; https://doi.org/10.1016/j.nbd.2022.105859</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>